|
| Agent | Reference | Result |
|
| Moutan cortex | [19] | Reduced concentration of TNF-, IL-1 and IL-6 in LPS-stimulated RAW264.7 cells |
| Moutan cortex | [20] | Increased production of IL-10 and a decrease in level of proinflammatory cytokines |
| Perillae Fructus | [21] | Suppressed IL-4 production, inhibiting IgE secretion; reduced IL-5 and IL-13; suppressed excess Th2 activity and rebalanced Th1/Th2 |
| Atractylenolide I | [22] | Up-regulate TNF; down-regulate IL-1 |
| Tibetan medicated-bath | [23] | Decreased IL-6 and TNF- levels |
| Opuntia humifusa Raf | [24] | Blocked expression of IL-6 from LPS-stimulated RAW264.7 cells |
| Total Flavonoids of Fructus Chorspondiatis | [25] | Inhibited NF-B signaling pathway |
| Artemisia annua L. | [26] | Inhibited IL-17A production; reduced mRNA expression of RORt; reduced IL-6 production |
| Kummerowia striata (Thunb.) Schindl ethanol extract | [27] | Suppressed NF-B activation; up-regulated IL-10 and HO-1 |
| Artemisia alba | [28] | Inhibited IL-1-induced NF-B and AP-1 activation |
| Ginger extract from Alpinia gallanga and Zingiber officinale | [28] | Reduced level of mRNA |
| Longicera japonica | [28] | Inhibited LPS-induced degradation of I-B and induction of NF-B p65, TNF- and inducible NO synthase (iNOS) |
| Phlebodium decumanum | [28] | Reduced TNF production; inhibited IL-6 production; increased release of TNF-R2 and IL-1 receptor agonist |
| Scandix austalis extracts | [28] | Inhibited IL-1-induced NF-B and AP-1 activation |
| Tripterygium wilfordii | [28] | Lowered the inflammatory response |
| Urtica dioica leaf extracts | [28] | Inhibited NF-B |
|
